Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
AADvac-1 Axon peptide 108 conjugated to KLH Alzheimer's Disease (Phase 2), Progressive Nonfluent Aphasia (Phase 1) Axon Neuroscience SE Tau Immunotherapy (active)
ABvac 40 Alzheimer's Disease (Phase 2) Araclon Biotech Amyloid-Related Immunotherapy (active)
Affitope AD02 Alzheimer's Disease (Phase 2) AFFiRiS AG Amyloid-Related Immunotherapy (active)
UB 311 Alzheimer's Disease (Phase 2) United Neuroscience Amyloid-Related Immunotherapy (active)